Breaking News Instant updates and real-time market news.

AIMT

Aimmune

, NSRGY

Nestle

$68.22

1.6 (2.40%)

08:04
11/28/16
11/28
08:04
11/28/16
08:04

Aimmune Therapeutics closes $145M investment by Nestle Health Science

Aimmune Therapeutics (AIMT) announced the closing of the $145M equity investment by Nestle (NSRGY) Health Science. Nestle Health Science purchased 7,552,084 shares of Aimmune's common stock at $19.20 per share on November 23, in a private placement transaction. The sale of shares was made pursuant to the terms of the Securities Purchase Agreement entered into on November 3, by Aimmune and Nestle Health Science, as previously reported by Aimmune. In connection with the closing of the equity investment, Greg Behar, CEO of Nestle Health Science, was appointed to Aimmune's board of directors on November 23. Aimmune has a total of 50,044,727 shares of common stock outstanding after taking into account the shares issued to Nestle Health Science. Additional details regarding the equity investment and strategic collaboration agreement can be found in Aimmune's Form 8-K filed with the SEC on November 4.

AIMT

Aimmune

NSRGY

Nestle

$68.22

1.6 (2.40%)

  • 29

    Nov

  • 01

    Dec

  • 14

    Dec

AIMT Aimmune

06/28/16
PIPR
06/28/16
NO CHANGE
Target $38
PIPR
Overweight
Piper reiterates Overweight on Aimmune after management meetings
After hosting meetings with management, Piper Jaffray analyst Charles Duncan reiterates an Overweight rating on Aimmune Therapeutics (AIMT) with a $38 price target. The stock closed yesterday down 44c to $11.01 and is down over 40% year-to-date. No matter how the Phase II data is dissected, Aimmune's AR101 appears to produce a higher response rate in about 50% less time than DBV Technologies' (DBVT) Viaskin, Duncan tells investors in a research note. He believes investors may be overlooking future potential drivers of competitive advantage for AR101.
08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Aimmune data positive, says Piper Jaffray
Piper Jaffray analyst Charles Duncan says that a study of Aimmune's OIT in very young children with peanut allergies indicates that it provides "clinically meaningful protection and perhaps even a disease modifying effect." The analyst says that the drug demonstrated "unexpectedly good" tolerability, and he believes that the data indicates that the drug could be differentiated versus the current standard of care. He keeps a $38 price target and Overweight rating on the stock.
09/21/16
PIPR
09/21/16
NO CHANGE
Target $38
PIPR
Overweight
Aimmune enrollment completion a 'big positive,' says Piper Jaffray
Piper Jaffray analyst Charles Duncan calls Aimmune Therapeutics' announcement yesterday that it completed North American enrollment of 350 patients in its Phase III PALISADE trial of AR101 as a "big positive." The faster than expected timelike "speaks to the unmet need in peanut allergy across the differentiated, broad patient population enrolled in PALISADE, Duncan tells investors in a research note. The analyst reiterates an Overweight rating on the shares with a $38 price target.
09/26/16
JMPS
09/26/16
INITIATION
Target $30
JMPS
Outperform
Aimmune initiated with an Outperform at JMP Securities
JMP Securities analyst Liisa Bayko initiated Aimmune with an Outperform and a $30 price target. The analyst is confident that AR101 Phase 3 data will show meaningful desensitization to peanuts in allergic children and adults and we will be paying close attention to safety and any discontinuations and projects $1.4B in sales by 2028.
NSRGY Nestle
$68.22

1.6 (2.40%)

08/11/16
SOCG
08/11/16
UPGRADE
SOCG
Buy
Nestle upgraded to Buy from Hold at Societe Generale
08/11/16
08/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Shake Shack (SHAK) upgraded to Buy from Neutral at SunTrust with analyst Jake Bartlett saying improved unit growth and its second quarter same-store sales miss creates a buying opportunity. 2. SeaWorld (SEAS) upgraded to Neutral from Underperform at Credit Suisse with analyst Benjamin Chalken citing recently lowered guidance, reset expectations, and balanced risk reward. 3. Cabot Oil & Gas (COG) upgraded to Outperform at Scotia Howard Weil with analyst Holly Stewart saying she expects infrastructure concerns will be reconciled by early 2018 with the inservice of 850 MMcf/d of contracted capacity and another 690 MMcf/d by early 2019. 4. American Eagle (AEO) upgraded to Buy from Hold at Wunderlich with analyst Eric Beder saying the company's momentum is "too strong" not to own the shares. 5. Nestle (NSRGY) upgraded to Buy from Hold at Societe Generale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
DBAB
09/09/16
UPGRADE
DBAB
Buy
Nestle upgraded to Buy from Hold at Deutsche Bank
09/13/16
GSCO
09/13/16
UPGRADE
GSCO
Buy
Nestle upgraded to Buy from Neutral at Goldman

TODAY'S FREE FLY STORIES

MGPI

MGP Ingredients

$49.51

-0.06 (-0.12%)

, CKH

Seacor

$32.30

-0.3 (-0.92%)

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Hot Stocks
MGP Ingredients reaches agreement to sell stake in ICP JV »

MGP Ingredients (MGPI)…

MGPI

MGP Ingredients

$49.51

-0.06 (-0.12%)

CKH

Seacor

$32.30

-0.3 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

$DJT

DJ Transportation Average

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.95

0.34 (1.04%)

, XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Hot Stocks
Teva, Xenon says phase 2 study of topical TV-45070 did not meet primary endpoint »

Teva Pharmaceutical…

TEVA

Teva

$32.95

0.34 (1.04%)

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

RICE

Rice Energy

$26.42

0.77 (3.00%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Downgrade
Rice Energy rating change  »

Rice Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$169.98

0.86 (0.51%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
06/27/17
06/27
08:20
06/27/17
08:20
General news
Fedspeak from Chair Yellen is atop the roster »

Fedspeak from Chair…

XLK

Technology Select Sector SPDR

$56.00

-0.3 (-0.53%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$64.24

-0.14 (-0.22%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$89.84

0.32 (0.36%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$54.01

0.16 (0.30%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$3.80

-0.04 (-1.04%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Hot Stocks
Agile Therapeutics resubmits NDA for Twirla contraceptive patch »

Agile Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$53.57

0.36 (0.68%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$39.59

0.09 (0.23%)

, CHTR

Charter

$332.65

1.85 (0.56%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Technical View: Sprint rallies as it enters deal talks with Charter, Comcast »

The stock was last up…

CMCSA

Comcast

$39.59

0.09 (0.23%)

CHTR

Charter

$332.65

1.85 (0.56%)

S

Sprint

$8.01

-0.04 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 03

    Aug

XLP

Consumer Staples Sector SPDR

$55.71

0.22 (0.40%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.95

0.34 (1.04%)

, XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Hot Stocks
Breaking Hot Stocks news story on Teva, Xenon Pharmaceuticals »

Teva, Xenon says phase 2…

TEVA

Teva

$32.95

0.34 (1.04%)

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

XLV

Health Care Select Sector SPDR

$80.39

-0.08 (-0.10%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$141.08

0.17 (0.12%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$213.87

0.13 (0.06%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.29

0.16 (0.07%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$27.62

0.69 (2.56%)

, FOXA

21st Century Fox

$28.04

0.85 (3.13%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Hot Stocks
21st Century Fox gets clearance from Republic of Ireland Minister for Sky deal »

21st Century Fox (FOX,…

FOX

21st Century Fox

$27.62

0.69 (2.56%)

FOXA

21st Century Fox

$28.04

0.85 (3.13%)

SKYAY

Sky

$49.20

0.2 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$24.02

0.13 (0.54%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$85.34

-0.33 (-0.39%)

08:16
06/27/17
06/27
08:16
06/27/17
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$90.66

-0.26 (-0.29%)

, PANW

Palo Alto Networks

$137.11

-1.3 (-0.94%)

08:16
06/27/17
06/27
08:16
06/27/17
08:16
Conference/Events
Maxim to hold a bus tour »

3rd Annual Silicon Valley…

VMW

VMware

$90.66

-0.26 (-0.29%)

PANW

Palo Alto Networks

$137.11

-1.3 (-0.94%)

NTAP

NetApp

$40.29

0.42 (1.05%)

PSTG

Pure Storage

$13.34

-0.15 (-1.11%)

SPLK

Splunk

$57.82

-0.61 (-1.04%)

HPE

HP Enterprise

$16.81

-0.04 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.